The seven-year term loan is price at 30-day LIBOR plus 4.25 percent. The revolving credit facility is priced at 30-day LIBOR plus 3.75 percent.
The new financing structure is expected to result is cash flow savings of $2 million annually.
More Articles on Transactions and Valuation Issues:
57 Ambulatory Surgery Centers Opened or Announced in 2014
USPI Acquires Majority Interest in Somerset Ambulatory Surgery Center
Houston Healthcare Expands Surgery Center
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.